Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

106 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prophylactic gastrostomy tube during chemoradiation for head and neck cancer decreases weight loss but increases rate of tube use beyond six months.
Almeida ND, Yu H, Iovoli AJ, Fang M, Schrand TV, Pepin A, Gupta V, Wooten KE, Markiewicz MR, McSpadden RP, Hicks WL Jr, Farrugia MK, Singh AK. Almeida ND, et al. Among authors: farrugia mk. Oral Oncol. 2025 Jan;160:107136. doi: 10.1016/j.oraloncology.2024.107136. Epub 2024 Dec 12. Oral Oncol. 2025. PMID: 39671770
Association of significant financial burden with survival for head and neck cancer patients treated with radiation therapy.
Ma SJ, Iovoli AJ, Attwood K, Wooten KE, Arshad H, Gupta V, McSpadden RP, Kuriakose MA, Markiewicz MR, Chan JM, Hicks WL, Platek ME, Ray AD, Repasky EA, Farrugia MK, Singh AK. Ma SJ, et al. Among authors: farrugia mk. Oral Oncol. 2021 Apr;115:105196. doi: 10.1016/j.oraloncology.2021.105196. Epub 2021 Feb 10. Oral Oncol. 2021. PMID: 33578203 Free PMC article.
Defining the optimal threshold and prognostic utility of pre-treatment hemoglobin level as a biomarker for survival outcomes in head and neck cancer patients receiving chemoradiation.
Ma SJ, Yu H, Khan M, Yu B, Santhosh S, Chatterjee U, Gill J, Iovoli A, Farrugia M, Wooten K, Gupta V, McSpadden R, Kuriakose MA, Markiewicz MR, Al-Afif A, Hicks WL Jr, Platek ME, Seshadri M, Ray AD, Repasky E, Singh AK. Ma SJ, et al. Oral Oncol. 2022 Oct;133:106054. doi: 10.1016/j.oraloncology.2022.106054. Epub 2022 Aug 5. Oral Oncol. 2022. PMID: 35933937 Free PMC article.
Association of pre-treatment lymphocyte-monocyte ratio with survival outcome in patients with head and neck cancer treated with chemoradiation.
Yu B, Ma SJ, Khan M, Gill J, Iovoli A, Fekrmandi F, Farrugia MK, Wooten K, Gupta V, McSpadden R, Kuriakose MA, Markiewicz MR, Al-Afif A, Hicks WL Jr, Seshadri M, Ray AD, Repasky EA, Singh AK. Yu B, et al. Among authors: farrugia mk. BMC Cancer. 2023 Jun 21;23(1):572. doi: 10.1186/s12885-023-11062-3. BMC Cancer. 2023. PMID: 37344761 Free PMC article.
Association of Nonsteroidal Anti-inflammatory Drug Use With Survival in Patients With Squamous Cell Carcinoma of the Head and Neck Treated With Chemoradiation Therapy.
Iovoli AJ, Hermann GM, Ma SJ, Platek AJ, Farrugia MK, Yau E, Wooten KE, Arshad H, Gupta V, Kuriakose MA, Hicks WL Jr, Singh AK. Iovoli AJ, et al. Among authors: farrugia mk. JAMA Netw Open. 2020 Jun 1;3(6):e207199. doi: 10.1001/jamanetworkopen.2020.7199. JAMA Netw Open. 2020. PMID: 32602907 Free PMC article.
A Principal Component of Quality of Life Measures Is Associated with Survival for Head and Neck Cancer Patients Treated with Radiation Therapy.
Farrugia M, Yu H, Ma SJ, Iovoli AJ, Attwood K, Wooten KE, Arshad H, Gupta V, McSpadden RP, Kuriakose MA, Markiewicz MR, Chan JM, Hicks WL Jr, Platek ME, Ray AD, Repasky EA, Singh AK. Farrugia M, et al. Cancers (Basel). 2021 Mar 8;13(5):1155. doi: 10.3390/cancers13051155. Cancers (Basel). 2021. PMID: 33800256 Free PMC article.
106 results